BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2513 related articles for article (PubMed ID: 15843387)

  • 1. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
    Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T
    Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assay of 855 test chemicals in ten tester strains using a new modification of the Ames test for bacterial mutagens.
    McMahon RE; Cline JC; Thompson CZ
    Cancer Res; 1979 Mar; 39(3):682-93. PubMed ID: 371791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
    Irwin RD
    Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the metabolizing capacity of S9 liver preparations from rats and mice using a test with Salmonella typhimurium TA100.
    Gajcy H; Pieńkowska K; Koziorowska J; Czarnomska A
    Pol J Pharmacol Pharm; 1987; 39(1):27-32. PubMed ID: 3313326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrogen-substitution effects on the mutagenicity and cytochrome P450 isoform-selectivity of chrysene analogs.
    Yamada K; Hakura A; Kato TA; Mizutani T; Saeki K
    Mutat Res; 2005 Sep; 586(1):87-95. PubMed ID: 16087391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenicity of carbon tetrachloride and chloroform in Salmonella typhimurium TA98, TA100, TA1535, and TA1537, and Escherichia coli WP2uvrA/pKM101 and WP2/pKM101, using a gas exposure method.
    Araki A; Kamigaito N; Sasaki T; Matsushima T
    Environ Mol Mutagen; 2004; 43(2):128-33. PubMed ID: 14991753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenicity of potassium alkanediazotates and their use as model compounds for activated nitrosamines.
    Hecker LI; Saavedra JE; Farrelly JG; Andrews AW
    Cancer Res; 1983 Sep; 43(9):4078-82. PubMed ID: 6347365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spectrum of enzymes involved in activation of 2-aminoanthracene varies with the metabolic system applied.
    Veres Z; Török G; Tóth E; Vereczkey L; Jemnitz K
    Mutat Res; 2005 Sep; 586(1):18-27. PubMed ID: 16006184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives.
    Utesch D; Glatt H; Oesch F
    Cancer Res; 1987 Mar; 47(6):1509-15. PubMed ID: 3545447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advantage of the use of human liver S9 in the Ames test.
    Hakura A; Suzuki S; Satoh T
    Mutat Res; 1999 Jan; 438(1):29-36. PubMed ID: 9858674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of human liver S9 in the Ames test: assay of three procarcinogens using human S9 derived from multiple donors.
    Hakura A; Suzuki S; Sawada S; Sugihara T; Hori Y; Uchida K; Kerns WD; Sagami F; Motooka S; Satoh T
    Regul Toxicol Pharmacol; 2003 Feb; 37(1):20-7. PubMed ID: 12662906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenicity in V79 cells does not correlate with carcinogenity in small rodents for 12 aromatic amines.
    Fassina G; Abbondandolo A; Mariani L; Taningher M; Parodi S
    J Toxicol Environ Health; 1990; 29(1):109-30. PubMed ID: 2299684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further examination of the effects of nitrosylation on Alternaria alternata mycotoxin mutagenicity in vitro.
    Schrader TJ; Cherry W; Soper K; Langlois I
    Mutat Res; 2006 Jul; 606(1-2):61-71. PubMed ID: 16698312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mutagenic activity of carcinogens and other chemical agents in Salmonella typhimurium tests].
    Khudoleĭ VV; Mizgirev IV; Pliss GB
    Vopr Onkol; 1986; 32(3):73-80. PubMed ID: 3515759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-silico screening of high production volume chemicals for mutagenicity using the MCASE QSAR expert system.
    Klopman G; Chakravarti SK; Harris N; Ivanov J; Saiakhov RD
    SAR QSAR Environ Res; 2003 Apr; 14(2):165-80. PubMed ID: 12747573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contamination is a frequent confounding factor in toxicology studies with anthraquinone and related compounds.
    Butterworth BE; Mathre OB; Ballinger KE; Adalsteinsson O
    Int J Toxicol; 2004; 23(5):335-44. PubMed ID: 15513832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of microsomal and cytosolic fractions from rat, mouse, and hamster liver on the mutagenicity of dimethylnitrosamine in the Salmonella plate incorporation assay.
    Prival MJ; Mitchell VD
    Cancer Res; 1981 Nov; 41(11 Pt 1):4361-7. PubMed ID: 7030474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro mutagenicity assays of chemical carcinogens and related compounds with Salmonella typhimurium.
    Simmon VF
    J Natl Cancer Inst; 1979 Apr; 62(4):893-9. PubMed ID: 372657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mutagenicity of mixtures of halogenated aliphatic hydrocarbons and polycyclic aromatic hydrocarbons in the Ames test with TA98 and TA100].
    Kevekordes S; Porzig J; Gebel T; Dunkelberg H
    Zentralbl Hyg Umweltmed; 1998 Feb; 200(5-6):531-41. PubMed ID: 9531725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased mutagenicity of chloroethylnitrosoureas in the presence of a rat liver S9 microsome mixture.
    Suling WJ; Rice LS; Shannon WM
    J Natl Cancer Inst; 1983 Apr; 70(4):767-9. PubMed ID: 6220173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 126.